Advanced Search:
Equity Index Forex Crypto Commodity

TECH - Bio-Techne Corp

$66.73  -2.08 (-3.02%)

Updated: 03:13 May 5, 2024 EST

Next Hour's AI Forecast

99.27%

Avg. Accuracy (AI)

$76.55

Next Session's AI Forecast

94.14%

Avg. Accuracy (AI)

$69.57

Next Week's AI Forecast

33.33%

Trend's Accuracy (AI)

$64.93

Bio-Techne Corp's Position Within the Biotechnology Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

BIO-TECHNE CORP - HISTORICAL DATA 6M

  • Last price

    $ 66.73

  • Daily change

    $ -2.08

  • Previous Close

    $ 68.81

  • Last Updated

    03:13 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.82 0.47 0.28 0.27 -0

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.9 2.39 1.89 1.72 1.58

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
100% 100% 100% 100%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
76.86 10.85% 69.34 1.45% 68.35 -0.54% 68.72

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.68 59.18 4.66 40.48

Bio-Techne Corp Technical Analysis News

Bio-Techne Corp

614 McKinley Place N.E.
Minneapolis, MN 55413
United States
612 379 8854
https://www.bio-techne.com

Sectors: Healthcare
Industry: Biotechnology
F. Time Employees: 3200
Description

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Corporate Governance

Bio-Techne Corporation’s ISS Governance QualityScore as of May 1, 2024 is 10. The pillar scores are Audit: 10; Board: 4; Shareholder Rights: 1; Compensation: 10.

BIO-TECHNE CORP'S HOLDERS RANK

List of holders with stock participation in Bio-Techne Corp.

Holder Rank Holder Shares Date Reported % Out Value